Ikena Oncology, Inc.
IKNA
$1.14
-$0.01-0.87%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 114.05M | 124.39M | 138.03M | 145.42M | 157.35M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 2.95M | 2.78M | 3.50M | 3.90M | 3.42M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | 400.00K |
Total Current Assets | 117.00M | 127.17M | 141.53M | 149.32M | 161.17M |
|
|||||
Total Current Assets | 117.00M | 127.17M | 141.53M | 149.32M | 161.17M |
Net Property, Plant & Equipment | 3.61M | 4.23M | 4.84M | 5.55M | 6.11M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 10.23M | 10.11M | 2.61M | 2.61M | 5.51M |
Total Assets | 130.84M | 141.51M | 148.99M | 157.49M | 172.78M |
|
|||||
Total Accounts Payable | 805.00K | 897.00K | 1.54M | 1.41M | 1.91M |
Total Accrued Expenses | 3.96M | 6.07M | 3.73M | 3.02M | 4.77M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.89M | 3.78M | 3.92M | 3.70M | 3.44M |
Total Finance Division Other Current Liabilities | 140.00K | 23.00K | 47.00K | 69.00K | 46.00K |
Total Other Current Liabilities | 140.00K | 23.00K | 47.00K | 69.00K | 46.00K |
Total Current Liabilities | 8.79M | 10.78M | 9.24M | 8.20M | 10.17M |
|
|||||
Total Current Liabilities | 8.79M | 10.78M | 9.24M | 8.20M | 10.17M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 2.72M | 3.74M | 4.47M | 5.40M | 6.30M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.08M | 1.06M | 1.05M | 1.03M | 964.00K |
Total Liabilities | 12.59M | 15.58M | 14.76M | 14.63M | 17.44M |
|
|||||
Common Stock & APIC | 458.39M | 457.49M | 456.49M | 455.47M | 454.19M |
Retained Earnings | -340.24M | -331.62M | -322.50M | -312.26M | -298.53M |
Treasury Stock & Other | 99.00K | 68.00K | 240.00K | -350.00K | -313.00K |
Total Common Equity | 118.25M | 125.93M | 134.23M | 142.86M | 155.35M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 118.25M | 125.93M | 134.23M | 142.86M | 155.35M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 118.25M | 125.93M | 134.23M | 142.86M | 155.35M |
|